Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)

HKG:2659 Revenue

Shanghai Bao Pharmaceuticals had revenue of 9.88M CNY in the half year ending June 30, 2026, with 562.31% growth. This brings the company's total for the last twelve months to 17.04M, down -63.48% year-over-year. In the year 2025, Shanghai Bao Pharmaceuticals had annual revenue of 49.16M with 697.99% growth. That makes Shanghai Bao Pharmaceuticals the 41,927th largest company in the world by revenue and 2,538th in Hong Kong.

• Revenue (ttm): 17.04M CNY
• Revenue Growth: -63.48%
• P/S Ratio: 157.76
• Revenue / Employee: 46.82K CNY
• Employees: 364
• Market Cap: 3.04B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.16M	43.00M	697.99%
Dec 31, 2024	6.16M	-770.00K	-11.11%
Dec 31, 2023	6.93M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 8, 2026

Data Sources Report a data error